As per the USFDA#39;s Orange Book contains that data of all approved drugs in US, the patents of Imbruvica will start expiry only from 2026, some patents are valid all the way till 2033-2034.from Moneycontrol Business News http://bit.ly/2ToZSur
Thursday, January 31, 2019
Natco braces for major patent battle in US, submits ANDA of cancer drug Imbruvica
As per the USFDA#39;s Orange Book contains that data of all approved drugs in US, the patents of Imbruvica will start expiry only from 2026, some patents are valid all the way till 2033-2034.from Moneycontrol Business News http://bit.ly/2ToZSur
Subscribe to:
Post Comments (Atom)
LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally
A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...
-
In a regulatory filing the company said the Odisha Electricity Regulatory Commission (OERC) has awarded the Letter of Intent (LOI) to Tata ...
-
A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...
No comments:
Post a Comment